238 related articles for article (PubMed ID: 29273385)
41. Caprine mucopolysaccharidosis IIID: fetal and neonatal brain and liver glycosaminoglycan and morphological perturbations.
Jones MZ; Alroy J; Downs-Kelly E; Lucas RE; Kraemer SA; Cavanagh KT; King B; Hopwood JJ
J Mol Neurosci; 2004; 24(2):277-91. PubMed ID: 15456941
[TBL] [Abstract][Full Text] [Related]
42. Morphological damage in Sertoli, myoid and interstitial cells in a mouse model of mucopolysaccharidosis type I (MPS I).
do Nascimento CC; Aguiar O; Viana GM; D'Almeida V
Mol Biol Rep; 2021 Jan; 48(1):363-370. PubMed ID: 33319323
[TBL] [Abstract][Full Text] [Related]
43. Mucopolysaccharidosis type I, II, IIIA and V. Pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain.
Dekaban AS; Constantopoulos G
Acta Neuropathol; 1977 Jul; 39(1):1-7. PubMed ID: 409090
[TBL] [Abstract][Full Text] [Related]
44. Fast, sensitive method for trisaccharide biomarker detection in mucopolysaccharidosis type 1.
Makino E; Klodnitsky H; Leonard J; Lillie J; Lund TC; Marshall J; Nietupski J; Orchard PJ; Miller WP; Phaneuf C; Tietz D; Varban ML; Donovan M; Belenki A
Sci Rep; 2018 Feb; 8(1):3681. PubMed ID: 29487322
[TBL] [Abstract][Full Text] [Related]
45. Intracerebroventricular transplantation of human bone marrow-derived multipotent progenitor cells in an immunodeficient mouse model of mucopolysaccharidosis type I (MPS-I).
Nan Z; Shekels L; Ryabinin O; Evavold C; Nelson MS; Khan SA; Deans RJ; Mays RW; Low WC; Gupta P
Cell Transplant; 2012; 21(7):1577-93. PubMed ID: 22472595
[TBL] [Abstract][Full Text] [Related]
46. Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.
Dickson P; Peinovich M; McEntee M; Lester T; Le S; Krieger A; Manuel H; Jabagat C; Passage M; Kakkis ED
J Clin Invest; 2008 Aug; 118(8):2868-76. PubMed ID: 18654665
[TBL] [Abstract][Full Text] [Related]
47. Prenatal diagnosis of Hurler's syndrome--biochemical studies on the affected fetus.
Ikeno T; Minami R; Wagatsuma K; Fujibayashi S; Nakao T; Abo K; Tsugawa S; Taniguchi S; Takasago Y
Hum Genet; 1981; 59(4):353-9. PubMed ID: 6800929
[TBL] [Abstract][Full Text] [Related]
48. Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation.
Kuiper GA; van Hasselt PM; Boelens JJ; Wijburg FA; Langereis EJ
Mol Genet Metab; 2017 Sep; 122(1-2):86-91. PubMed ID: 28684085
[TBL] [Abstract][Full Text] [Related]
49. The levels of urinary glycosaminoglycans of patients with attenuated and severe type of mucopolysaccharidosis II determined by liquid chromatography-tandem mass spectrometry.
Mashima R; Sakai E; Tanaka M; Kosuga M; Okuyama T
Mol Genet Metab Rep; 2016 Jun; 7():87-91. PubMed ID: 27331006
[TBL] [Abstract][Full Text] [Related]
50. Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system.
Shull RM; Hastings NE; Selcer RR; Jones JB; Smith JR; Cullen WC; Constantopoulos G
J Clin Invest; 1987 Feb; 79(2):435-43. PubMed ID: 3100576
[TBL] [Abstract][Full Text] [Related]
51. Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.
Kakkis ED; McEntee MF; Schmidtchen A; Neufeld EF; Ward DA; Gompf RE; Kania S; Bedolla C; Chien SL; Shull RM
Biochem Mol Med; 1996 Aug; 58(2):156-67. PubMed ID: 8812735
[TBL] [Abstract][Full Text] [Related]
52. Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells.
Baldo G; Quoos Mayer F; Burin M; Carrillo-Farga J; Matte U; Giugliani R
Cells Tissues Organs; 2012; 195(4):323-9. PubMed ID: 21778683
[TBL] [Abstract][Full Text] [Related]
53. Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I.
Dierenfeld AD; McEntee MF; Vogler CA; Vite CH; Chen AH; Passage M; Le S; Shah S; Jens JK; Snella EM; Kline KL; Parkes JD; Ware WA; Moran LE; Fales-Williams AJ; Wengert JA; Whitley RD; Betts DM; Boal AM; Riedesel EA; Gross W; Ellinwood NM; Dickson PI
Sci Transl Med; 2010 Dec; 2(60):60ra89. PubMed ID: 21123810
[TBL] [Abstract][Full Text] [Related]
54. Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients.
Coppa GV; Buzzega D; Zampini L; Maccari F; Galeazzi T; Pederzoli F; Gabrielli O; Volpi N
Glycobiology; 2010 Oct; 20(10):1259-73. PubMed ID: 20538645
[TBL] [Abstract][Full Text] [Related]
55. Reduction of lysosome abundance and GAG accumulation after odiparcil treatment in MPS I and MPS VI models.
Tuyaa-Boustugue P; Jantzen I; Zhang H; Young SP; Broqua P; Tallandier M; Entchev E
Mol Genet Metab Rep; 2023 Dec; 37():101011. PubMed ID: 38053941
[TBL] [Abstract][Full Text] [Related]
56. Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry.
Kubaski F; Mason RW; Nakatomi A; Shintaku H; Xie L; van Vlies NN; Church H; Giugliani R; Kobayashi H; Yamaguchi S; Suzuki Y; Orii T; Fukao T; Montaño AM; Tomatsu S
J Inherit Metab Dis; 2017 Jan; 40(1):151-158. PubMed ID: 27718145
[TBL] [Abstract][Full Text] [Related]
57. [Mucopolysaccharidosis V (Ullrich-Scheie syndrome) (author's transl)].
Kovarik J; Vormittag W; Gebhart W; Ruthner U; Lubec G; Molzer B
Wien Klin Wochenschr; 1978 Dec; 90(23):839-44. PubMed ID: 154210
[TBL] [Abstract][Full Text] [Related]
58. Prediction of neuropathology in mucopolysaccharidosis I patients.
Fuller M; Brooks DA; Evangelista M; Hein LK; Hopwood JJ; Meikle PJ
Mol Genet Metab; 2005 Jan; 84(1):18-24. PubMed ID: 15639191
[TBL] [Abstract][Full Text] [Related]
59. Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease.
Kingma SDK; Wagemans T; IJlst L; Bronckers ALJJ; van Kuppevelt TH; Everts V; Wijburg FA; van Vlies N
Bone; 2016 Jul; 88():92-100. PubMed ID: 27105565
[TBL] [Abstract][Full Text] [Related]
60. Intraperitoneal implant of recombinant encapsulated cells overexpressing alpha-L-iduronidase partially corrects visceral pathology in mucopolysaccharidosis type I mice.
Baldo G; Mayer FQ; Martinelli B; Meyer FS; Burin M; Meurer L; Tavares AM; Giugliani R; Matte U
Cytotherapy; 2012 Aug; 14(7):860-7. PubMed ID: 22472038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
